Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. Victoria ...
Tag: Biotech and Pharmaceuticals
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New ...
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers ...
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, ...
Gilead stock falls after disappointing lung cancer study results
Sopa Images | Lightrocket | Getty ImagesShares of Gilead fell more than 9% on Monday after a key drug from ...
CVS to close ‘select’ pharmacies in Target stores in the coming months
CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail ...
Walgreens stock plunges after drugstore chain slashes quarterly dividend nearly in half
Shares of Walgreens fell more than 11% on Thursday after the company reported fiscal first-quarter adjusted earnings and revenue that ...
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) ...
Here are the big health sector themes to watch next year
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021.David W. Cerny ...
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or ...
